๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Heterocyclic ketones as inhibitors of histone deacetylase

โœ Scribed by Anil Vasudevan; Zhiqin Ji; Robin R. Frey; Carol K. Wada; Douglas Steinman; H.Robin Heyman; Yan Guo; Michael L. Curtin; Jun Guo; Junling Li; Lori Pease; Keith B. Glaser; Patrick A. Marcotte; Jennifer J. Bouska; Steven K. Davidsen; Michael R. Michaelides

Book ID
108073098
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
249 KB
Volume
13
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Dietary agents as histone deacetylase in
Dietary agents as histone deacetylase inhibitors
โœ Melinda C. Myzak; Emily Ho; Roderick H. Dashwood ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB

## Abstract In cancer cells, an imbalance often exists between histone acetyltransferase (HAT) and histone deacetylase (HDAC) activities, and various drug companies are actively seeking competitive HDAC inhibitors for chemotherapeutic intervention. Cancer cells appear to be more sensitive than nont

Novel Sulfonamide Derivatives as Inhibit
Novel Sulfonamide Derivatives as Inhibitors of Histone Deacetylase
โœ Paulโ€…W. Finn; Morwena Bandara; Chris Butcher; Angela Finn; Ruth Hollinshead; Nag ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ German โš– 374 KB

## Abstract Inhibition of the enzyme histone deacetylase (HDAC) is emerging as a novel approach to the treatment of cancer. A series of novel sulfonamide derivatives were synthesized and evaluated for their ability to inhibit human HDAC. Compounds were identified which are potent enzyme inhibitors,